President Donald Trump had to be begged not to spill the beans about a seismic change to U.S. drug policy made this month, according to a report from The Wall Street Journal published on Saturday.

After extensive lobbying and some generous donations from major players in the marijuana industry, the president was convinced to follow through with his campaign promise to shift cannabis from a Schedule I to Schedule III substance during a meeting with Kim Rivers, the CEO of Florida-based cannabis company Trulieve, Trump confidante Howard Kessler and Florida Sheriff Gordon Smith in early December.

Eager to share the news immediately, Trump told the people in the room he planned to announce the decision on Truth Social before an executive order was even drafted.

Smith remembered things getting heated as Oval Office insiders tried to stop their boss from blabbing, according to the Journal.

“The lawyers and his staff, they started yelling, ’No sir, you can’t yet; there’s a 30-day period, it’s gotta go through this and that,” Smith recalled.“They had to stop him from posting.”

It was surreal display, according to the sheriff, who told the paper, “I was in awe of the whole thing.”

Trump, a teetotaler with a hard stance against illicit drugs, flouted the wishes of a sizable faction of Republicans with the move, which was made official with a Dec. 18 executive order.

Speaker of the House Mike Johnson (R-La.) was reportedly on speakerphone during the president’s meeting with Rivers, Smith and Kessler, where he argued that marijuana was a dangerous “gateway drug.”

Cannabis had held Schedule I status since the Controlled Substances Act became law in 1970, categorizing it alongside heroin, cocaine and methamphetamine as drugs that have “no currently accepted medical use and a high potential for abuse.”